title: Recipient selection algorithm for immunosuppression in cardiac transplantation: OKT3 vs triple therapy alone.
authors.affiliation: Nationally Funded Centre for Heart and Lung Transplantation, Alfred Hospital, Melbourne, Australia.
authors.forename: M
authors.initials: M
authors.lastname: Rabinov
authors.forename: E
authors.initials: E
authors.lastname: Benson
authors.forename: A
authors.initials: A
authors.lastname: Cochrane
authors.forename: T
authors.initials: T
authors.lastname: Williams
authors.forename: P
authors.initials: P
authors.lastname: Bergin
authors.forename: J
authors.initials: J
authors.lastname: Federman
authors.forename: D
authors.initials: D
authors.lastname: Esmore
mesh_terms: D000328:Adult; D000465:Algorithms; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D011446:Prospective Studies; D012307:Risk Factors
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3